Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Top Cited Papers
Open Access
- 1 February 2004
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 25 (1), 102-152
- https://doi.org/10.1210/er.2002-0022
Abstract
This review focuses on the systemic complications of acromegaly. Mortality in this disease is increased mostly because of cardiovascular and respiratory diseases, although currently neoplastic complications have been questioned as a relevant cause of increased risk of death. Biventricular hypertrophy, occurring independently of hypertension and metabolic complications, is the most frequent cardiac complication. Diastolic and systolic dysfunction develops along with disease duration; and other cardiac disorders, such as arrhythmias, valve disease, hypertension, atherosclerosis, and endothelial dysfunction, are also common in acromegaly. Control of acromegaly by surgery or pharmacotherapy, especially somatostatin analogs, improves cardiovascular morbidity. Respiratory disorders, sleep apnea, and ventilatory dysfunction are also important contributors in increasing mortality and are beneficially advantaged by controlling GH and IGF-I hypersecretion. An increased risk of colonic polyps, which more frequently recur in patients not controlled after treatment, has been reported by several independent investigations, although malignancies in other organs have also been described, but less convincingly than at the gastrointestinal level. Finally, the most important cause of morbidity and functional disability of the disease is arthropathy, which can be reversed at an initial stage, but not if the disease is left untreated for several years.Keywords
This publication has 376 references indexed in Scilit:
- Insulin-like Growth Factor-I Promotes Proliferation and Migration of Cavernous Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2001
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Acromegaly and thyroid carcinomaClinical Endocrinology, 1996
- Hormonal Regulation of Serum Lipoprotein(a) LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- An Association between Acromegaly and Thyroid CarcinomaThyroid®, 1995
- Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell lineEuropean Journal of Cancer, 1992
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyThe New England Journal of Medicine, 1990
- AcromegalyThe New England Journal of Medicine, 1990
- COLON CANCER AND POLYPS IN ACROMEGALY: INCREASED RISK ASSOCIATED WITH FAMILY HISTORY OF COLON CANCERClinical Endocrinology, 1990
- Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor IBiochemical and Biophysical Research Communications, 1988